Filed: 8/14/2024ACC: 0001172661-24-003525
📋 What this filing means
SUVRETTA CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 98 equity positions with a total reported market value of $2.72B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
98
Positions
$2.72B
Total AUM (reported)
130.85M
Total Shares
Allocation by class
COM$1.70B62.3%
TR UNIT$272.11M10.0%
COM PAR $.01$168.96M6.2%
CL A$138.52M5.1%
COM NEW$114.81M4.2%
COMMON STOCK$89.53M3.3%
SPONSORED ADS$65.32M2.4%
Portfolio Concentration
Top 3$621.54M22.8%
4–10$680.79M25.0%
11–25$759.15M27.9%
Rest$660.82M24.3%
Top 3 weight
22.8%
Top 10 weight
47.8%
Voting Authority Distribution
Total shares with voting rights: 130.85M
Sole
Full voting authority
130.85M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole98
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings98
Rows:
SPDR S&P 500 ETF TR
SOLEShares500K
TypeSH
Market value$272.11M
10.00%
Sole
500K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares5.20M
TypeSH
Market value$180.46M
6.63%
Sole
5.20M
Shared
0.00
None
0.00
INSMED INC
SOLEShares2.52M
TypeSH
Market value$168.96M
6.21%
Sole
2.52M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares7.07M
TypeSH
Market value$145.56M
5.35%
Sole
7.07M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares1.57M
TypeSH
Market value$107.26M
3.94%
Sole
1.57M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares10M
TypeSH
Market value$93.04M
3.42%
Sole
10M
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares2.06M
TypeSH
Market value$84.72M
3.11%
Sole
2.06M
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares167.17K
TypeSH
Market value$84.29M
3.10%
Sole
167.17K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares1.52M
TypeSH
Market value$83.68M
3.07%
Sole
1.52M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares161.47K
TypeSH
Market value$82.23M
3.02%
Sole
161.47K
Shared
0.00
None
0.00
APPLE INC
SOLEShares363.36K
TypeSH
Market value$76.53M
2.81%
Sole
363.36K
Shared
0.00
None
0.00
AMAZON COM INC
SOLEShares356.27K
TypeSH
Market value$68.85M
2.53%
Sole
356.27K
Shared
0.00
None
0.00
89BIO INC
SOLEShares8.03M
TypeSH
Market value$64.34M
2.36%
Sole
8.03M
Shared
0.00
None
0.00
TAIWAN SEMICONDUCTOR MFG LTD
SOLEShares350.75K
TypeSH
Market value$60.96M
2.24%
Sole
350.75K
Shared
0.00
None
0.00
ADVANCED MICRO DEVICES INC
SOLEShares346K
TypeSH
Market value$56.12M
2.06%
Sole
346K
Shared
0.00
None
0.00
ELEVANCE HEALTH INC
SOLEShares91.44K
TypeSH
Market value$49.55M
1.82%
Sole
91.44K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares4.19M
TypeSH
Market value$49.38M
1.81%
Sole
4.19M
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares1.87M
TypeSH
Market value$49.22M
1.81%
Sole
1.87M
Shared
0.00
None
0.00
MICROSOFT CORP
SOLEShares104.03K
TypeSH
Market value$46.50M
1.71%
Sole
104.03K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares5.18M
TypeSH
Market value$45.03M
1.65%
Sole
5.18M
Shared
0.00
None
0.00
APOLLO GLOBAL MGMT INC
SOLEShares354.49K
TypeSH
Market value$41.85M
1.54%
Sole
354.49K
Shared
0.00
None
0.00
AT&T INC
SOLEShares2.19M
TypeSH
Market value$41.79M
1.54%
Sole
2.19M
Shared
0.00
None
0.00
SYSCO CORP
SOLEShares520.90K
TypeSH
Market value$37.19M
1.37%
Sole
520.90K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares2.05M
TypeSH
Market value$36.16M
1.33%
Sole
2.05M
Shared
0.00
None
0.00
COCA COLA CO
SOLEShares560.61K
TypeSH
Market value$35.68M
1.31%
Sole
560.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 500K | SH | $272.11M 10.00% | 500K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 5.20M | SH | $180.46M 6.63% | 5.20M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 2.52M | SH | $168.96M 6.21% | 2.52M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 7.07M | SH | $145.56M 5.35% | 7.07M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 1.57M | SH | $107.26M 3.94% | 1.57M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 10M | SH | $93.04M 3.42% | 10M | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 2.06M | SH | $84.72M 3.11% | 2.06M | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 167.17K | SH | $84.29M 3.10% | 167.17K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 1.52M | SH | $83.68M 3.07% | 1.52M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 161.47K | SH | $82.23M 3.02% | 161.47K | 0.00 | 0.00 |
APPLE INCSOLE | COM | 363.36K | SH | $76.53M 2.81% | 363.36K | 0.00 | 0.00 |
AMAZON COM INCSOLE | COM | 356.27K | SH | $68.85M 2.53% | 356.27K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 8.03M | SH | $64.34M 2.36% | 8.03M | 0.00 | 0.00 |
TAIWAN SEMICONDUCTOR MFG LTDSOLE | SPONSORED ADS | 350.75K | SH | $60.96M 2.24% | 350.75K | 0.00 | 0.00 |
ADVANCED MICRO DEVICES INCSOLE | COM | 346K | SH | $56.12M 2.06% | 346K | 0.00 | 0.00 |
ELEVANCE HEALTH INCSOLE | COM | 91.44K | SH | $49.55M 1.82% | 91.44K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 4.19M | SH | $49.38M 1.81% | 4.19M | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 1.87M | SH | $49.22M 1.81% | 1.87M | 0.00 | 0.00 |
MICROSOFT CORPSOLE | COM | 104.03K | SH | $46.50M 1.71% | 104.03K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 5.18M | SH | $45.03M 1.65% | 5.18M | 0.00 | 0.00 |
APOLLO GLOBAL MGMT INCSOLE | COM | 354.49K | SH | $41.85M 1.54% | 354.49K | 0.00 | 0.00 |
AT&T INCSOLE | COM | 2.19M | SH | $41.79M 1.54% | 2.19M | 0.00 | 0.00 |
SYSCO CORPSOLE | COM | 520.90K | SH | $37.19M 1.37% | 520.90K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 2.05M | SH | $36.16M 1.33% | 2.05M | 0.00 | 0.00 |
COCA COLA COSOLE | COM | 560.61K | SH | $35.68M 1.31% | 560.61K | 0.00 | 0.00 |
Page 1 of 4